Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke

Aims - To investigate European guideline treatment target achievement in cardiovascular risk factors, medication use, and lifestyle, after myocardial infarction (MI) or ischaemic stroke, in women and men living in Norway. Methods and results - In the population-based Tromsø Study 2015–16 (attendance...

Full description

Bibliographic Details
Published in:European Journal of Preventive Cardiology
Main Authors: Hopstock, Laila Arnesdatter, Morseth, Bente, Cook, Sarah, Eggen, Anne Elise, Grimsgaard, Sameline, Lundblad, Marie Wasmuth, Løchen, Maja-Lisa, Mathiesen, Ellisiv B., Nilsen, Amalie, Njølstad, Inger
Format: Article in Journal/Newspaper
Language:English
Published: Cambrigde University Press 2021
Subjects:
Online Access:https://hdl.handle.net/10037/23027
https://doi.org/10.1093/eurjpc/zwab050
id ftunivtroemsoe:oai:munin.uit.no:10037/23027
record_format openpolar
spelling ftunivtroemsoe:oai:munin.uit.no:10037/23027 2023-05-15T18:34:31+02:00 Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke Hopstock, Laila Arnesdatter Morseth, Bente Cook, Sarah Eggen, Anne Elise Grimsgaard, Sameline Lundblad, Marie Wasmuth Løchen, Maja-Lisa Mathiesen, Ellisiv B. Nilsen, Amalie Njølstad, Inger 2021-03-29 https://hdl.handle.net/10037/23027 https://doi.org/10.1093/eurjpc/zwab050 eng eng Cambrigde University Press European Journal of Preventive Cardiology (EJPC) Hopstock LA, Morseth B, Cook S, Eggen AE, Grimsgaard sg, Lundblad MW, Løchen M, Mathiesen EB, Nilsen A, Njølstad i. Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke. European Journal of Preventive Cardiology (EJPC). 2021 FRIDAID 1952450 doi:10.1093/eurjpc/zwab050 2047-4873 2047-4881 https://hdl.handle.net/10037/23027 openAccess Copyright 2021 The Author(s) VDP::Medical disciplines: 700::Health sciences: 800::Community medicine Social medicine: 801 VDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin sosialmedisin: 801 Journal article Tidsskriftartikkel Peer reviewed publishedVersion 2021 ftunivtroemsoe https://doi.org/10.1093/eurjpc/zwab050 2021-11-17T23:54:38Z Aims - To investigate European guideline treatment target achievement in cardiovascular risk factors, medication use, and lifestyle, after myocardial infarction (MI) or ischaemic stroke, in women and men living in Norway. Methods and results - In the population-based Tromsø Study 2015–16 (attendance 65%), 904 participants had previous validated MI and/or stroke. Cross-sectionally, we investigated target achievement for blood pressure (<140/90 mmHg, <130/80 mmHg if diabetes), LDL cholesterol (<1.8 mmol/L), HbA1c (<7.0% if diabetes), overweight (body mass index (BMI) <25 kg/m2, waist circumference women <80 cm, men <94 cm), smoking (non-smoking), physical activity (self-reported >sedentary, accelerometer-measured moderate-to-vigorous ≥150 min/week), diet (intake of fruits ≥200 g/day, vegetables ≥200 g/day, fish ≥200 g/week, saturated fat <10E%, fibre ≥30 g/day, alcohol women ≤10 g/day, men ≤20 g/day), and medication use (antihypertensives, lipid-lowering drugs, antithrombotics, and antidiabetics), using regression models. Proportion of target achievement was for blood pressure 55.2%, LDL cholesterol 9.0%, HbA1c 42.5%, BMI 21.1%, waist circumference 15.7%, non-smoking 86.7%, self-reported physical activity 79%, objectively measured physical activity 11.8%, intake of fruit 64.4%, vegetables 40.7%, fish 96.7%, saturated fat 24.3%, fibre 29.9%, and alcohol 78.5%, use of antidiabetics 83.6%, lipid-lowering drugs 81.0%, antihypertensives 75.9%, and antithrombotics 74.6%. Only 0.7% achieved all cardiovascular risk factor targets combined. Largely, there was little difference between the sexes, and in characteristics, medication use, and lifestyle among target achievers compared to non-achievers. Conclusion - Secondary prevention of cardiovascular disease was suboptimal. A negligible proportion achieved the treatment target for all risk factors. Improvement in follow-up care and treatment after MI and stroke is needed. Article in Journal/Newspaper Tromsø University of Tromsø: Munin Open Research Archive Norway Tromsø European Journal of Preventive Cardiology 29 2 362 370
institution Open Polar
collection University of Tromsø: Munin Open Research Archive
op_collection_id ftunivtroemsoe
language English
topic VDP::Medical disciplines: 700::Health sciences: 800::Community medicine
Social medicine: 801
VDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin
sosialmedisin: 801
spellingShingle VDP::Medical disciplines: 700::Health sciences: 800::Community medicine
Social medicine: 801
VDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin
sosialmedisin: 801
Hopstock, Laila Arnesdatter
Morseth, Bente
Cook, Sarah
Eggen, Anne Elise
Grimsgaard, Sameline
Lundblad, Marie Wasmuth
Løchen, Maja-Lisa
Mathiesen, Ellisiv B.
Nilsen, Amalie
Njølstad, Inger
Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke
topic_facet VDP::Medical disciplines: 700::Health sciences: 800::Community medicine
Social medicine: 801
VDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin
sosialmedisin: 801
description Aims - To investigate European guideline treatment target achievement in cardiovascular risk factors, medication use, and lifestyle, after myocardial infarction (MI) or ischaemic stroke, in women and men living in Norway. Methods and results - In the population-based Tromsø Study 2015–16 (attendance 65%), 904 participants had previous validated MI and/or stroke. Cross-sectionally, we investigated target achievement for blood pressure (<140/90 mmHg, <130/80 mmHg if diabetes), LDL cholesterol (<1.8 mmol/L), HbA1c (<7.0% if diabetes), overweight (body mass index (BMI) <25 kg/m2, waist circumference women <80 cm, men <94 cm), smoking (non-smoking), physical activity (self-reported >sedentary, accelerometer-measured moderate-to-vigorous ≥150 min/week), diet (intake of fruits ≥200 g/day, vegetables ≥200 g/day, fish ≥200 g/week, saturated fat <10E%, fibre ≥30 g/day, alcohol women ≤10 g/day, men ≤20 g/day), and medication use (antihypertensives, lipid-lowering drugs, antithrombotics, and antidiabetics), using regression models. Proportion of target achievement was for blood pressure 55.2%, LDL cholesterol 9.0%, HbA1c 42.5%, BMI 21.1%, waist circumference 15.7%, non-smoking 86.7%, self-reported physical activity 79%, objectively measured physical activity 11.8%, intake of fruit 64.4%, vegetables 40.7%, fish 96.7%, saturated fat 24.3%, fibre 29.9%, and alcohol 78.5%, use of antidiabetics 83.6%, lipid-lowering drugs 81.0%, antihypertensives 75.9%, and antithrombotics 74.6%. Only 0.7% achieved all cardiovascular risk factor targets combined. Largely, there was little difference between the sexes, and in characteristics, medication use, and lifestyle among target achievers compared to non-achievers. Conclusion - Secondary prevention of cardiovascular disease was suboptimal. A negligible proportion achieved the treatment target for all risk factors. Improvement in follow-up care and treatment after MI and stroke is needed.
format Article in Journal/Newspaper
author Hopstock, Laila Arnesdatter
Morseth, Bente
Cook, Sarah
Eggen, Anne Elise
Grimsgaard, Sameline
Lundblad, Marie Wasmuth
Løchen, Maja-Lisa
Mathiesen, Ellisiv B.
Nilsen, Amalie
Njølstad, Inger
author_facet Hopstock, Laila Arnesdatter
Morseth, Bente
Cook, Sarah
Eggen, Anne Elise
Grimsgaard, Sameline
Lundblad, Marie Wasmuth
Løchen, Maja-Lisa
Mathiesen, Ellisiv B.
Nilsen, Amalie
Njølstad, Inger
author_sort Hopstock, Laila Arnesdatter
title Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke
title_short Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke
title_full Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke
title_fullStr Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke
title_full_unstemmed Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke
title_sort treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – the tromsø study 2015-2016. secondary prevention in myocardial infarction and stroke
publisher Cambrigde University Press
publishDate 2021
url https://hdl.handle.net/10037/23027
https://doi.org/10.1093/eurjpc/zwab050
geographic Norway
Tromsø
geographic_facet Norway
Tromsø
genre Tromsø
genre_facet Tromsø
op_relation European Journal of Preventive Cardiology (EJPC)
Hopstock LA, Morseth B, Cook S, Eggen AE, Grimsgaard sg, Lundblad MW, Løchen M, Mathiesen EB, Nilsen A, Njølstad i. Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke. European Journal of Preventive Cardiology (EJPC). 2021
FRIDAID 1952450
doi:10.1093/eurjpc/zwab050
2047-4873
2047-4881
https://hdl.handle.net/10037/23027
op_rights openAccess
Copyright 2021 The Author(s)
op_doi https://doi.org/10.1093/eurjpc/zwab050
container_title European Journal of Preventive Cardiology
container_volume 29
container_issue 2
container_start_page 362
op_container_end_page 370
_version_ 1766219297072349184